๐ค AI Summary
This work addresses the challenge of balancing multiple competing constraints in molecular optimization with large language models (LLMs). It proposes the first reinforcement learningโbased post-training framework for controllable multi-objective molecular generation, integrating grouped relative optimization, alignment of property scores across heterogeneous objectives, and continuous nonlinear reward aggregation. By aligning LLMs with continuous multi-objective drug design requirements through reinforcement learning post-training, the method significantly enhances optimization stability across competing properties. Evaluated on the C-MuMOInstruct benchmark, it achieves optimization rates of 48.9% on in-distribution (IND) tasks and 39.5% on out-of-distribution (OOD) tasks, while effectively preserving molecular scaffold similarity.
๐ Abstract
Large language models (LLMs) show promise for molecular optimization, but aligning them with selective and competing drug-design constraints remains challenging. We propose C-Moral, a reinforcement learning post-training framework for controllable multi-objective molecular optimization. C-Moral combines group-based relative optimization, property score alignment for heterogeneous objectives, and continuous non-linear reward aggregation to improve stability across competing properties. Experiments on the C-MuMOInstruct benchmark show that C-Moral consistently outperforms state-of-the-art models across both in-domain and out-of-domain settings, achieving the best Success Optimized Rate (SOR) of 48.9% on IND tasks and 39.5% on OOD tasks, while largely preserving scaffold similarity. These results suggest that RL post-training is an effective way to align molecular language models with continuous molecular design objectives. Our code and models are publicly available at https://github.com/Rwigie/C-MORAL.